Exact Mass: 308.1736

Exact Mass Matches: 308.1736

Found 33 metabolites which its exact mass value is equals to given mass value 308.1736, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

bestatin

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

C16H24N2O4 (308.1736)


KEIO_ID B018; [MS2] KO009090 KEIO_ID B018 Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].

   

8-Hydroxycarteolol

5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydroquinoline-2,8-diol

C16H24N2O4 (308.1736)


8-Hydroxycarteolol is a metabolite of carteolol. Carteolol (trade names Cartrol, Ocupress, Teoptic, Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Poenglaucol, Singlauc) is a non-selective beta blocker used to treat glaucoma. (Wikipedia)

   

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

C16H24N2O4 (308.1736)


   

Diacetolol

RS-1-(4-acetamido-2-Acetylphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride

C16H24N2O4 (308.1736)


   

Ubenimex

(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

C16H24N2O4 (308.1736)


Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia. Ubenimex is a microbial metabolite and dipeptide with potential immunomodulatory and antitumor activities. Ubenimex competitively inhibits many aminopeptidases, including B, N and leucine aminopeptidases. Aminopeptidases has been implicated in the process of cell adhesion and invasion of tumor cells. Therefore, inhibiting aminopeptidases may partially attribute to the antitumor effect of ubenimex. This agent also activates T lymphocyte, macrophage and bone marrow stem cell as well as stimulates release of interleukin-1 and -2, thus further enhances its antitumor activity. D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D000970 - Antineoplastic Agents D007155 - Immunologic Factors Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].

   
   

Diacetolol

Diacetolol

C16H24N2O4 (308.1736)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   
   
   

Ubenimex (Bestatin)

Ubenimex (Bestatin)

C16H24N2O4 (308.1736)


   

8-Hydroxycarteolol

8-Hydroxycarteolol

C16H24N2O4 (308.1736)


   

4-Boc-7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

4-Boc-7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

C16H24N2O4 (308.1736)


   

boc-phe-n(och3)ch3

boc-phe-n(och3)ch3

C16H24N2O4 (308.1736)


   

tert-butyl N-[1-(benzylamino)-3-methoxy-1-oxopropan-2-yl]carbamate

tert-butyl N-[1-(benzylamino)-3-methoxy-1-oxopropan-2-yl]carbamate

C16H24N2O4 (308.1736)


   

N,N-DI-TERT-BUTOXYCARBONYL-BENZENE-1,4-DIAMINE

N,N-DI-TERT-BUTOXYCARBONYL-BENZENE-1,4-DIAMINE

C16H24N2O4 (308.1736)


   

(S)-ETHYL 3-(4-AMINOPHENYL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOATE

(S)-ETHYL 3-(4-AMINOPHENYL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOATE

C16H24N2O4 (308.1736)


   

Benzeneacetic acid,2-[2-(dipropylamino)ethyl]-6-nitro-

Benzeneacetic acid,2-[2-(dipropylamino)ethyl]-6-nitro-

C16H24N2O4 (308.1736)


   

(R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate

(R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate

C16H24N2O4 (308.1736)


   

TERT-BUTYL 2-(1-(4-(ETHOXYCARBONYL)PHENYL)ETHYL)HYDRAZINECARBOXYLATE

TERT-BUTYL 2-(1-(4-(ETHOXYCARBONYL)PHENYL)ETHYL)HYDRAZINECARBOXYLATE

C16H24N2O4 (308.1736)


   

2-[(3-Azaniumyl-2-hydroxy-4-phenylbutanoyl)amino]-4-methylpentanoate

2-[(3-Azaniumyl-2-hydroxy-4-phenylbutanoyl)amino]-4-methylpentanoate

C16H24N2O4 (308.1736)


   

N-(2,5-diethoxy-4-morpholin-4-ylphenyl)acetamide

N-(2,5-diethoxy-4-morpholin-4-ylphenyl)acetamide

C16H24N2O4 (308.1736)


   

N-[(2R,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2R,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2S,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2S,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2S,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2R,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2R,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

N-[(2S,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C16H24N2O4 (308.1736)


   

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid

C16H24N2O4 (308.1736)


Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].

   

[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine

[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine

C16H24N2O4 (308.1736)


   

(2s)-2-{[(2s,3r)-3-amino-1,2-dihydroxy-4-phenylbutylidene]amino}-4-methylpentanoic acid

(2s)-2-{[(2s,3r)-3-amino-1,2-dihydroxy-4-phenylbutylidene]amino}-4-methylpentanoic acid

C16H24N2O4 (308.1736)


   

2-[(3-amino-1,2-dihydroxy-4-phenylbutylidene)amino]-4-methylpentanoic acid

2-[(3-amino-1,2-dihydroxy-4-phenylbutylidene)amino]-4-methylpentanoic acid

C16H24N2O4 (308.1736)